Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention



Status:Active, not recruiting
Conditions:Blood Cancer, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:18 - Any
Updated:3/7/2019
Start Date:September 29, 2015
End Date:May 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Preliminary Evaluation of an Internet-Assisted Cognitive Behavioral Intervention for Targeted Therapy Fatigue

The purpose of this study is to evaluate Cognitive Behavioral Intervention for Targeted
Therapy Fatigue (CBT-TTF) with fatigued chronic myelogenous leukemia (CML) patients on
tyrosine kinase inhibitors (TKIs) for feasibility, acceptability and potential efficacy
relative to usual care only in a small-scale randomized controlled trial.


Inclusion Criteria:

- able to speak/read English

- diagnosed with chronic phase CML

- not have been treated for other cancer (except non-melanoma skin cancer) in the past 5
years

- be under the care of a Moffitt Cancer Center (MCC) physician

- be on a stable dose of the same oral TKI for >= 3 months

- new onset or worsening of fatigue since starting TKI

- report moderate-severe fatigue in past week (FSI average rating >= 4 of 0-10)

- have no clinical history of disease (e.g., multiple sclerosis, fibromyalgia) that
could account for their fatigue presentation

Exclusion Criteria:

- scheduled to discontinue their TKI under medical supervision within the next 3 months
We found this trial at
1
site
H. Lee Moffitt Cancer Center & Research Institute
12902 USF Magnolia Dr
Tampa, Florida 33612
(888) 663-3488
Principal Investigator: Heather Jim, Ph.D.
Phone: 813-745-1810
H. Lee Moffitt Cancer Center & Research Institute Moffitt Cancer Center in Tampa, Florida, has...
?
mi
from
Tampa, FL
Click here to add this to my saved trials